Corticosteroid Injection as a Predictor of Outcome in Carpal Tunnel Release

NCT ID: NCT00655915

Last Updated: 2011-03-09

Basic Information

• Recruitment Status: TERMINATED
• Total Enrollment: 200 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2007-12-31
• Study Completion Date: 2011-03-31

Brief Summary

This study will investigate whether symptomatic improvement following carpal tunnel corticosteroid injection can be correlated to symptomatic improvement following carpal tunnel release and therefore serve as a prognostic indicator.

Clinical question: Does response to corticosteroid injection in CTS predict outcomes of surgical treatment?

Secondary Questions:

1. Can we confirm previous retrospectively collected data that a certain percentage of conservatively managed patients with steroid injection will avoid surgery, and that patients who undergo surgery will have better outcomes than those who do not.

2. Are there differences between worker's compensation and non-worker's compensation patients with regard to the primary clinical question?

3. What are Carpal Tunnel Release outcomes for the subset of patients with negative electrophysiologic studies?

4. What are the outcomes of patients who undergo carpal tunnel release vs. those who choose not to undergo carpal tunnel release?

A prospective cohort design study is the appropriate study design in order to measure the association between a predictor (response to injection) and outcome (response to surgery).

Detailed Description

Carpal Tunnel Syndrome is a painful condition that is caused by compression of the median nerve in the wrist. Symptoms usually are pain, weakness, or numbness in the hand and wrist, radiating up the arm. Corticosteroid injections have been utilized in the conservative management of carpal tunnel syndrome for several decades. They have been shown to be relatively safe with a very low reported complication rate. Recent efforts in the literature have shown they are efficacious for a majority of patients although their effects are usually transient. Several studies have attempted to show a predictive value of corticosteroid injection with regard to who will ultimately benefit from carpal tunnel release. There is a trend towards positive predictability with several retrospective studies showing that patients who have a clinical benefit from steroid injection are more likely to have a successful outcome from carpal tunnel release. Carpal tunnel release remains the definitive treatment option for carpal tunnel syndrome, and a clinical test which could give the practitioner and patient additional information regarding likelihood of successful outcome of surgery would be a valuable prognostic tool.

Conditions

Carpal Tunnel Syndrome

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Injection Patients

Those patients who receive corticosteroid injections for carpal tunnel syndrome

Corticosteroid Injection- 1ml of Betamethasone and 1 ml of 1% Lidocaine

Intervention Type: OTHER

Patients will receive a carpal tunnel injection of 1 mg of betamethasone and 1 mL of 1% lidocaine will be infiltrated by small gauge (ie. 25- or 27-gauge) needle via attending surgeon preference. These are routinely performed by injecting 1cm proximal to distal wrist crease just ulnar to palmaris longus tendon although multiple techniques have been described. Elicitation of median nerve symptoms during needle placement requires redirecting needle prior to injection to avoid median nerve infiltration.

Interventions

Corticosteroid Injection- 1ml of Betamethasone and 1 ml of 1% Lidocaine

Patients will receive a carpal tunnel injection of 1 mg of betamethasone and 1 mL of 1% lidocaine will be infiltrated by small gauge (ie. 25- or 27-gauge) needle via attending surgeon preference. These are routinely performed by injecting 1cm proximal to distal wrist crease just ulnar to palmaris longus tendon although multiple techniques have been described. Elicitation of median nerve symptoms during needle placement requires redirecting needle prior to injection to avoid median nerve infiltration.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patients with a clinical diagnosis of carpal tunnel syndrome
• English speaking patients only

Exclusion Criteria

• Patients less than 18 years old
• Patients who are pregnant by patient report or intending to become pregnant during the study
• Patients unwilling or unable to return for follow-up visits prescribed by the study protocol.
• Patients who qualify for inclusion in the study, but refuse to participate.
• Patients with evidence of thenar atrophy on exam
• Patients with a diagnosis of peripheral neuropathy or other neuropathy.
• Patients with previous ipsilateral carpal tunnel injection or release.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Vanderbilt University

OTHER

Sponsor Role: lead

Responsible Party

Vanderbilt University Medical Center

Principal Investigators

Jeffry T Watson, M.D.

Role: PRINCIPAL_INVESTIGATOR

Vanderbilt University

Locations

Vanderbilt Hand & Upper Extremity Center

Nashville, Tennessee, United States

Countries

United States

Other Identifiers

071107

Identifier Type: -

Identifier Source: org_study_id